$6.04
0.11.68%
Last update: Nov 5, 4:41 AM
Evommune Inc
EVMNNYSE
The average analyst price target for Evommune is $31.11, 330.3% above the current price. Of 12 analysts, 9 rate it Buy and 3 Hold. Targets range from $8 to $53. The latest change came on Oct 12, 2026, when UBS initiated coverage of Evommune with a Neutral rating and a $8 price target.
Price Target Range — 5 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months
